Prevalence of simple nodular goiter and Hashimoto's thyroiditis in current, previous, and never smokers in a geographical area with mild iodine deficiency

Hormone and Metabolic Research

Volumn 47, Issue 3, 2015, Pages 214-219

  Rendina, D ^a,b   De Palma, D ^a,c   De Filippo, G ^a   De Pascale, F ^a   Muscariello, R ^a   Ippolito, R ^a   Fazio, V ^a   Fiengo, A ^a   Benvenuto, D ^b   Strazzullo, P ^a   Galletti, F ^a,c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Spinelli Hospital   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

cross sectional study; fine needle aspiration biopsy; nonmalignant thyroid diseases; tabagism; ultrasonography

Indexed keywords

ANTITHYROID AGENT; IODINE; LEVOTHYROXINE; THYROGLOBULIN; THYROID PEROXIDASE ANTIBODY; THYROTROPIN;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GEOGRAPHIC DISTRIBUTION; HASHIMOTO DISEASE; HUMAN; HYPOTHYROIDISM; IODINE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NECK; NODULAR GOITER; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SIMPLE NODULAR GOITER; SMOKING; SMOKING CESSATION; SMOKING HABIT; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA; URINARY EXCRETION; ADVERSE EFFECTS; BLOOD; DEFICIENCY; GOITER; ITALY; VERY ELDERLY;

NICOTIANA TABACUM;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; GOITER; HASHIMOTO DISEASE; HUMANS; IODINE; ITALY; MALE; MIDDLE AGED; PREVALENCE; SMOKING;

EID: 84924249908     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0034-1387702     Document Type: Article

References (41)

1. Vanderpump M. P. The epidemiology of thyroid disease. Br Med Bull: 2011; 99 39 51
2. Hegedüs L., Bonnema S. J., Bennedbaek F. N. Management of simple nodular goiter: current status and future perspectives. Endocr Rev: 2003; 24 102 132
3. Sostre S., Reyes M. M. Sonographic diagnosis and grading of Hashimoto's thyroiditis. J Endocrinol Invest: 1991; 14 115 121
4. Caturegli P., De Remigis A., Rose N. R. Hashimoto thyroiditis: Clinical and diagnostic criteria. Autoimmun Rev: 2014; 13 391 397
5. Kapoor D., Jones T. H. Smoking and hormones in health and endocrine disorders. Eur J Endocrinol: 2005; 152 491 499
6. Willi C., Bodenmann P., Ghali W. A., Faris P. D., Cornuz J. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA: 2007; 298 2654 2664
7. Need A. G., Kemp A., Giles N., Morris H. A., Horowitz M., Nordin B. E. Relationship between intestinal calcium absorption, serum vitamin D metabolites and smoking in postmenopausal women. Osteoporos Int: 2002; 13 83 88
8. Vestergaard P. Smoking and thyroid disorders - a meta-analysis. Eur J Endocrinol: 2002; 146 153 161
9. Wiersinga W. M. Smoking and thyroid. ClinEndocrinol (Oxf): 2013; 79 145 151
10. Rendina D., De Filippo G., Mossetti G., Zampa G., Muscariello R., Benvenuto G., Vivona C. L., Ippolito S., Galante F., Lombardi G., Biondi B., Strazzullo P. Relationship between metabolic syndrome and multinodular non-toxic goiter in an inpatient population from a geographic area with moderate iodine deficiency. J Endocrinol Invest: 2012; 35 407 412
11. Rendina D., Gianfrancesco F., De Filippo G., Merlotti D., Esposito T., Aloia A., Benvenuto D., Vivona C. L., Annunziata G., Nuti R., Strazzullo P., Mossetti G., Gennari L. Epidemiological, clinical, and genetic characteristics of Paget's disease of bone in a rural area of Calabria, Southern Italy. J Endocrinol Invest: 2010; 33 519 525
12. Rendina D., Mossetti G., De Filippo G., Benvenuto D., Vivona C. L., Imbroinise A., Zampa G., Ricchio S., Strazzullo P. Association between metabolic syndrome and nephrolithiasis in an inpatient population in southern Italy: role of gender, hypertension and abdominal obesity. Nephrol Dial Transplant: 2009; 24 900 906
13. Biondi B., Cooper D. S. The clinical significance of subclinical thyroid dysfunction. Endocr Rev: 2008; 829 76 131
14. Barbesino G. Drugs affecting thyroid function. Thyroid: 2010; 20 763 770
15. Tognini S., Marchini F., Dardano A., Polini A., Ferdeghini M., Castiglioni M., Monzani F. Non-thyroidal illness syndrome and short-term survival in a hospitalised older population. Age Ageing: 2010; 39 46 50
16. Hegedüs L., Perrild H., Poulsen L. R., Andersen J. R., Holm B., Schnohr P., Jensen G., Hansen J. M. The determination of thyroid volume by ultrasound and its relationship to body weight, age and sex in normal subjects. J Clin Endocrinol Metab: 1983; 56 260 263
17. Hegedüs L. Thyroid ultrasonography as a screening tool for thyroid disease. Thyroid: 2004; 14 879 800
18. Krohn K., Führer D., Bayer Y., Eszlinger M., Brauer V., Neumann S., Paschke R. Molecular pathogenesis of euthyroid and toxic multinodular goiter. Endocr Rev: 2005; 26 504 524
19. Frates M. C., Benson C. B., Charboneau J. W., Cibas E. S., Clark O. H., Coleman B. G., Cronan J. J., Doubilet P. M., Evans D. B., Goellner J. R., Hay I. D., Hertzberg B. S., Intenzo C. M., Jeffrey R. B., Langer J. E., Larsen P. R., Mandel S. J., Middleton W. D., Reading C. C., Sherman S. I., Tessler F. N. Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement. Ultrasound Q: 2006; 22 231 240
20. Papini E., Guglielmi R., Bianchini A., Crescenzi A., Taccogna S., Nardi F., Panunzi C., Rinaldi R., Toscano V., Pacella C. M. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab: 2002; 87 1941 1946
21. Prignot J. Quantification and chemical markers of tobacco-exposure. Eur J Respir Dis: 1987; 70 1 7
22. Wood D. M., Mould M. G., Ong S. B., Baker E. H. Pack year smoking histories: what about patients who use loose tobacco? Tob Control: 2005; 14 141 142
23. Grundy S. M., Cleeman J. I., Daniels S. R., Donato K. A., Eckel R. H., Franklin B. A., Gordon D. J., Krauss R. M., Savage P. J., Smith S. C. Jr, Spertus J. A., Costa F. American Heart Association National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart association/National Heart, Lung and Blood Institute Scientific Statement. Circulation: 2005; 112 2735 2752
24. Palomba S., Numis F. G., Mossetti G., Rendina D., Vuotto P., Russo T., Zullo F., Nappi C., Nunziata V. Raloxifene administration in post-menopausal women with osteoporosis: effect of different BsmI vitamin D receptor genotypes. Hum Reprod: 2003; 18 192 198
25. Mellor C. S. Nomogram for calculating mass of alcohol in different beverages. Br Med J: 1970; 3 703
26. Knudsen N., Laurberg P., Perrild H., Bülow I., Ovesen L., Jorgensen T. Risk factors for goiter and thyroid nodules. Thyroid: 2002; 12 879 888
27. Ericsson U. B., Lindgarde F. Effects of cigarette smoking on thyroid function and the prevalence of goitre, thyrotoxicosis and autoimmune thyroiditis. J Intern Med: 1991; 229 69 71
28. Galanti M. R., Granath F., Cnattingius S., Ekbom-Schnell A., Ekbom A. Cigarette smoking and the risk of goitre and thyroid nodules amongst parous women. J Intern Med: 2005; 258 257 264
29. Knudsen N., Bülow I., Laurberg P., Ovesen L., Perrild H., Jorgensen T. Association of tobacco smoking with goiter in a low-iodine-intake area. Arch Intern Med: 2002; 162 439 443
30. Knudsen N., Bülow I., Laurberg P., Perrild H., Ovesen L., Jorgensen T. High occurrence of thyroid multinodularity and low occurrence of subclinical hypothyroidism among tobacco smokers in a large population study. J Endocrinol: 2002; 175 571 576
31. Ittermann T., Schmidt C. O., Kramer A., Below H., John U., Thamm M., Wallaschofski H., Völzke H. Smoking as a risk factor for thyroid volume progression and incident goiter in a region with improved iodine supply. Eur J Endocrinol: 2008; 159 761 766
32. Gu X. L., Mao J. Y., Shan Z. Y., Teng X. C., Teng D., Guan H. X., Li Y. S., Yu X. H., Fan C. L., Chong W., Yang F., Dai H., Yu Y., Li J., Chen Y. Y., Zhao D., Yang R., Jiang Y. Q., Li C. Y., Teng W. P. Epidemiological study of the effects of smoking cigarette on thyroid gland. Zhonghua Liu Xing Bing Xue Za Zhi: 2007; 28 53 56
33. Aydin L. Y., Aydin Y., Besir F. H., Demirin H., Yildirim H., Önder E., Dumlu T., Celbek G. Effect of smoking intensity on thyroid volume, thyroid nodularity and thyroid function: the Melen study. Minerva Endocrinol: 2011; 36 273 280
34. Pedersen I. B., Laurberg P., Knudsen N., Jorgensen T., Perrild H., Ovesen L., Rasmussen L. B. Smoking is negatively associated with the presence of thyroglobulin autoantibody and to a lesser degree with thyroid peroxidase autoantibody in serum: a population study. Eur J Endocrinol: 2008; 158 367 373
35. Carlé A., Bülow Pedersen I., Knudsen N., Perrild H., Ovesen L., Banke Rasmussen L., Jorgensen T., Laurberg P. Smoking cessation is followed by a sharp but transient rise in the incidence of overt autoimmune hypothyroidism - a population-based, case-control study. Clin Endocrinol (Oxf): 2012; 77 764 772
36. Tziomalos K., Charsoulis F. Endocrine effects of tobacco smoking. Clin Endocrinol (Oxf): 2004; 61 664 674
37. Brauer V. F., Below H., Kramer A., Führer D., Paschke R. The role of thiocyanate in the etiology of goiter in an industrial metropolitan area. Eur J Endocrinol: 2006; 154 229 235
38. Fukayama H., Nasu M., Murakami S., Sugawara M. Examination of antithyroid effects of smoking products in cultured thyroid follicles: only thiocyanate is a potent antithyroid agent. Acta Endocrinol (Copenh): 1992; 127 520 525
39. Brix T. H., Hegedus L. Twin studies as a model for exploring the aetiology of autoimmune thyroid disease. Clin Endocrinol (Oxf): 2012; 76 457 464
40. Gallus S., Muttarak R., Martínez-Sánchez J. M., Zuccaro P., Colombo P., La Vecchia C. Smoking prevalence and smoking attributable mortality in Italy, 2010. Prev Med: 2011; 52 434 438
41. Tramacere I., Gallus S., Zuccaro P., Colombo P., Rossi S., Boffetta P., La Vecchia C. Socio-demographic variation in smoking habits: Italy, 2008. Prev Med: 2009; 48 213 217